Chemical Characterization - Agina
Chemical Characterization - Agina
Chemical Characterization - Agina
Individual standards in the ISO 10993 series that specifically apply to the
chemical characterization process include:
ISO 10993-18
ISO 10993-18 is a standard that outlines the process for conducting chemical
characterization of a medical device to ensure its overall biological safety. The goal is to
provide detailed information on the materials used, chemical constituents, and potential
chemical release. The characterization procedure includes establishing the device's
configuration and material composition, assessing material equivalence to a clinically
established material or medical device, assessing the hypothetical worst-case chemical
release based on total exposure, establishing an analytical evaluation threshold, estimating
the chemical release, performing an extraction study, assessing the estimated chemical
release, determining the actual chemical release, and performing a leachables study. The
standard also outlines the analytical evaluation threshold (AET) for the device, which is
calculated and verified in Annex.
The ISO 10993 series applies when the material or medical device has direct or indirect
body contact.
Compositional approach
The document describes device configuration, material composition, and other factors,
including patient exposure and material use history. It assesses risk through a tox
assessment and a broad biological evaluation.
Considerations
Composition information always needed, and may be sufficient • Materials with extensive
clinical use history • Well understood materials (e.g., ASTM Nitinol vascular stents) •
Devices/materials with short or non-invasive contact (e.g., ureteral dilator, bandages
Leachable – a chemical substance that is released from a device during its clinical use
Extractable – substance that is released from a medical device or material of construction
when the medical device or material is extracted using laboratory extraction conditions and
vehicles.
Extraction Considerations
• Consider ISO 10993-12, but don’t be constrained by it
• For example, samples may need to be diluted or concentrated
• Regulators generally expect both polar and non-polar extraction vehicles, where possible
• In addition to polar and non-polar extraction vehicles, use of a 3rd, semi-polar vehicle
expected for long term contact (e.g., implants)
• If a non-polar solvent degrades material(s), use a less non-polar solvent.